Oncotarget is a peer-reviewed medical journal that is open-access and has achieved a high Impact Factor in the research community. The journal, published by Impact Journals, was started in 2010 by Dr. Mikhail Blagosklonny and Dr. Andrei V. Gudkov. Both doctors work at the Roswell Park Cancer Institute in Buffalo, New York and are co-editors-in-chief of Oncotarget. Oncotarget was originally focused on the field of Oncology but has recently expanded into accepting research papers in multiple medical disciplines and new issues are released weekly.
Dr. Mikhail Blagosklonny is a Professor of Oncology at the institute. He also conducts research that includes molecular and cellular biology. He also performs clinical investigations into tumor suppressors, anticancer therapeutics, and signal induction among other areas. He also conducts research into the cancer drug rapamycin and how it can be used for life extension due to the way it affects TOR signaling. Dr. Blagosklonny has written over 300 research papers, book chapters, and reviews. He is also an editor or assistant editor for several other journals in addition to Oncotarget.
Dr. Andre V. Gudkov also performs research into cancer treatment. He also holds two chairs at the Roswell Park Cancer Institute including the Senior Vice President of Basic Science Chair in Cell Stress Biology and the Garman Family Chair in Cell Stress Biology. His research involves DNA damage and repair and photodynamic therapy in addition to other research efforts he is involved in.
Oncotarget’s mission is to make scientific research results widely available as quickly as possible. The journal also seeks to break down the walls between different medical disciplines in order to foster interdisciplinary discussion and collaborative scientific research. Some of the research papers that they know publish, in addition to Oncology, are now in several specialties including among them Cardiology, Cell Biology, Endocrinology, and Pharmacology.
Beyond Oncology the Oncotarget website now has 5 additional sections. These sections are Chromosome, Immunology and Cell Death, Gerotarget/Aging, Pathology Beyond Oncology, and Immunology and Microbiology. With the addition of these new sections Oncotarget seeks to contribute to the progress of science in making life without disease possible.